HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Vulvar Cancer

Vulvar Cancer

Vulvar cancer, though relatively rare, can profoundly impact women's health. Research into this form of cancer focuses on early detection methods, personalized treatment options, and improving quality of life for patients. Scientists explore the role of HPV infection, smoking, and other risk factors in the development of vulvar cancer. Novel therapeutic approaches, including immunotherapy and targeted therapies, are being investigated to enhance treatment efficacy and reduce side effects. Additionally, efforts are underway to raise awareness about symptoms, promote regular screenings, and destigmatize discussions surrounding vulvar health. Collaborative efforts between researchers, healthcare providers, and advocacy groups are essential to advance our understanding of vulvar cancer and improve outcomes for those affected.

Committee Members
Committee Member - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
Committee Member - Atif A Ahmed

Atif A Ahmed

Seattle Children’s Hospital, United States
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
CIOC 2027 Speakers
Thomas Jay Webster

Thomas Jay Webster

Brown University, United States
Eleni Petsalaki

Eleni Petsalaki

University of Crete, Greece
Saumya Pandey

Saumya Pandey

Indira IVF Hospital, India

Submit your abstract Today

YouTube
WhatsAppWhatsApp